AMBALALSAPharmaceuticals

Ambalal Sarabhai Enterprises LtdQuarterly Results & Earnings

24.27
-4.23%
Profit Growth YoY-121.37%Latest quarter
Sales Growth YoY-0.56%Latest quarter
Sales CAGR 5Y8.08%5 year compound
Profit CAGR 5Y-8.94%5 year compound
📋

Quarterly Performance

YoY Profit Growth-121.37%
🔴 Significant decline
YoY Sales Growth-0.56%
⚠️ Mild contraction
OPM 5Y Average
Operating profit margin
5.24%
EPS Growth 5Y
-8.94%
Interest Coverage
Higher = safer debt servicing
4.87
ROE
6.25%
ROCE
9.12%
💡

Growth Analysis

Ambalal Sarabhai Enterprises Ltd reported YoY profit growth of -121.37% and revenue growth of -0.56% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 8.08% and profits at -8.94% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.